BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Landos Biopharma

Landos Biopharma logo

Founded
2017
Patents
10
Clinical Trials
8
Publications
8

Technologies

AI Companies (Drug Discovery)

Landos Biopharma, Inc. is an emerging biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune diseases. Landos’ lead clinical asset, BT-11, is a novel, locally-acting small molecule targeting inflammatory bowel disease (IBD) that is expected to enter clinical testing for Crohn’s disease in 2018. Landos also has a robust pipeline of compounds for other autoimmune diseases. Landos is headquartered in Blacksburg, VA.

Become a Member to view additional information about this company